Using Ki-67 positivity as a marker for cell proliferation, we found that MEK and Hh signaling inhibition simultaneously reduces proliferation of the metastatic cancer cells in the mouse model (Figure 3). This evidence concerns the gene MKI67 and metastatic malignant neoplasm.